there is growing experimental and clinical evidence that indapamide , an antihypertensive agent with only limited diuretic activity at low dosage ( 2.5 mg as a single dose per day ) , is proving to be a consistently effective and well-tolerated alternative to the thiazides and beta-blockers as a first-line treatment , and a useful addition in multi-drug regimens .
C0021186
indapamide
C2266870
diuretic activity